缅北禁地

Qualifications

BSc (Hons) Biomedical Science (Pharmacology), University of Aberdeen

PhD (Pharmacokinetics), Manchester University

Membership

International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT)

British Pharmacological Society (BPS)

The British Association for Cancer Research (BACR)

Children’s Cancer and Leukaemia Group (CCLG)

I am currently a Lecturer in Cancer Pharmacology at 缅北禁地 within the Centre for Cancer. My main focus of research is in the area of paediatric clinical pharmacology. Primarily investigating the pharmacokinetics of chemotherapeutics used to treat challenging paediatric patient populations, such as neonates and infants.

Research Interests

• Paediatric Pharmacokinetics/ Clinical Pharmacology
• Therapeutic Drug Monitoring (TDM)
• Drug-Drug Interactions (DDIs)
• Endogenous biomarkers for DDI prediction
• Micro-sampling techniques

• Articles

  • Millen GC, Lawford A, Duncan C, Jenkinson H, Veal GJ, Barnett S. . British Journal of Cancer 2024, 131, 491-497.
  • Mohmaed Ali MI, Nijstad AL, Boosman RJ, Crombag M-RBS, Barnett S, Veal GJ, Lalmohamed A, van Erp NP, Steeghs N, Zwaan CM, Beijnen JH, Siebinga H, Huitema ADR. . Clinical Pharmacokinetics 2024, 63, 1711-1722.
  • Damoiseaux D, Amant F, Beijnen JH, Barnett S, Veal GJ, Huitema ADR, Dorlo TPC. . CPT: Pharmacometrics and Systems Pharmacology 2023, 12(12), 1931-1944.
  • Barnett S, Makin G, Tweddle DA, Osborne C, Veal GJ. . British Journal of Cancer 2023, 129, 1773–1779.
  • Barnett S, Nyein AC, Galler M, Jamieson D, Davies M, Connor P, Veal GJ. . Cancer Chemotherapy and Pharmacology 2023, 92, 325–328.
  • Barnett S, Hellman F, Parke E, Makin G, Tweddle DA, Osborne C, Hempel G, Veal GJ. . European Journal of Cancer 2022, 164, 127-136.
  • Carruthers V, Barnett S, Rees R, Arif T, Slater O, Ramanujachar R, Johnson K, Brown S, Graham C, Burke GAA, Veal GJ. . Pediatric Blood and Cancer 2022, 69(7), e29722.
  • Nijstad AL, Chu W-Y, de Vos-Kerkhof E, Enters-Weijnen CF, van de Velde ME, Kaspers GJL, Barnett S, Veal GJ, Lalmohamed A, Zwaan CM, Huitema ADR. . Pharmaceutical Research 2022, 39, 2487-2495.
  • Barnett S, Errington J, Sludden J, Jamieson D, Poinsignon V, Paci A, Veal GJ. . Pharmaceuticals 2021, 14(3), 272.
  • Takita H, Barnett S, Zhang Y, Ménochet M, Shen H, Ogungbenro K, Galetin A. . CPT: Pharmacometrics & Systems Pharmacology 2021, 10(2), 137-147.
  • Barnett S, Ogungbenro K, Menochet K, Shen H, Humphreys GW, Galetin A. . Journal of Pharmacology and Experimental Therapeutics 2019, 368(1), 125-135.
  • Barnett S, Ogungbenro K, Ménochet K, Shen H, Lai Y, Humphreys WG, Galetin A. . Clinical Pharmacology & Therapeutics 2018, 104(3), 564-574.
  • Beedie SL, Rore HM, Barnett S, Chau CH, Luo W, Greig NH, Figg WD, Vargesson N. . Oncotarget 2016, 7(22), 33237-33245.
  • Beedie SL, Peer CJ, Pisle S, Gardner ER, Mahony C, Barnett S, Ambrozak A, Gütschow M, Chau CH, Vargesson N, Figg WD. . Molecular Cancer Therapeutics 2015, 14(10), 2228-2237.

• Letter

  • Geurten C, Errington J, Barnett S, Patel H, Noor S, Saraff V, Veal GJ, Gatz SA. . Pediatric Blood and Cancer 2023, 70(9), e30430.

• Reviews

  • Berezowska M, Hayden IS, Brandon AM, Zats A, Patel M, Barnett S, Ogungbenro K, Veal GJ, Taylor A, Suthar J. . British Journal of Clinical Pharmacology 2025, 91(4), 1064-1079.
  • Barnett S, Holden V, Campbell-Hewson Q, Veal GJ. . Frontiers in Oncology 2022, 11, 815040.
  • Nijstad AL, Barnett S, Lalmohamed A, Bérénos IM, Parke E, Carruthers V, Tweddle DA, Kong J, Zwaan CM, Huitema ADR, Veal GJ. . European Journal of Cancer 2022, 164, 137-154.
  • Barnett S, Kong J, Makin G, Veal GJ. . British Journal of Clinical Pharmacology 2021, 87(2), 256-262.